Closing Bell: Bausch Health Companies Inc down on Friday (BHC)
Today, Bausch Health Companies Inc stock opened at $7.55 and closed at $7.79. It traded at a low of $7.17 to a high of $8.04.
Shares eased -8.03% from the previous day's close of $8.47.
Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.
Bausch Health Companies Inc traded under BHC on the Toronto Stock Exchange (TSX).
Trading volume was 746,919 on 3,394 total trades. On average, Bausch Health Companies Inc has traded 573,883 shares over 5 days and 388,307 year-to-date.
The TSX overall saw 432 price advancers against 4,843 declines and 43 unchanged.
During the prior 52 weeks, BHC.TO has traded as high as $15.43 (April 03,2024) and low as $5.45 (July 24,2024). Moreover, in the last 12 months, Bausch Health Companies Inc's shares have shrunken -37.53 percent, while in 2024, they have shrunken -26.72%.
It announced a 1.00 dividend on November 05/10, with an November 10/10 ex-date and December 22/10 pay day.
Following today's trading, Bausch Health Companies Inc has a market capitalization of $2.86 billion on a float of 367,103 shares outstanding. Its annual EPS is $-1.29.
Bausch Health Companies Inc is a TSX Drug Specialty & Generic company headquartered in Laval, CAN.
Currently, Bausch Health Companies Inc's consensus rating is "Hold" based on 7 analysts according to Zacks. From those 7 analysts, 1 have buy ratings, 2 have sell ratings and 4 analysts gave hold ratings.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..